Med. praxi. 2011;8(12):532-536
In the last year we were in the area of pain management met with a number of innovations. They were published new recommended
practices for the treatment of neuropathic pain EFNS, there were new active substances and new formulations. The news for systemic
administration are mainly new transmucosal fentanyl for the treatment of breakthrough pain in cancer patients and a new active substance
tapentadol, which should appear first retarded form and subsequently in the form of a quick release. Is enriched by a group of
steroid anti-inflammatory drugs lornoxicam a new molecule. Interesting news appeared in the local treatment of neuropathic pain,
postherpetic pain for the treatment is intended to patch 5% and lidocaine for the treatment of mononeuropathies patch for a single
injection with 8% capsaicin.
Published: December 15, 2011 Show citation